High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.1M
$5,108,835
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Dieter David
• Officer • EVP & General Counsel
10b5-1 Sell
2026-03-09
$228,110
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Officer • EVP & General Counsel
10b5-1 Sell
|
2026-03-09 | $228,110 | S | Form 4 |
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Dreyer Scott
• Officer • EVP & Chief Commercial Officer
10b5-1 Sell
2026-03-03
$145,879
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Officer • EVP & Chief Commercial Officer
10b5-1 Sell
|
2026-03-03 | $145,879 | S | Form 4 |
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Dreyer Scott
• Officer • EVP & Chief Commercial Officer
10b5-1 SellΔOwn -38.1%
2026-03-03
$1,873,557Large
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Officer • EVP & Chief Commercial Officer
10b5-1 SellΔOwn -38.1%
|
2026-03-03 | $1,873,557Large | S | Form 4 |
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Fallon John A.
• Director
Discretionary SellΔOwn -35.0%
2025-11-12
$1,645,536Large
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Director
Discretionary SellΔOwn -35.0%
|
2025-11-12 | $1,645,536Large | S | Form 4 |
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Director
Other
|
2025-11-12 | $247,350 | M | Form 4 |
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
Director
Other
|
2025-11-12 | $185,228 | M | Form 4 |
|
COLL
S
COLLEGIUM PHARMACEUTICAL, INC
Tupper Colleen
• CFO
10b5-1 SellΔOwn -16.1%
2025-11-06
$1,015,236Large
|
||||||
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
CFO
10b5-1 SellΔOwn -16.1%
|
2025-11-06 | $1,015,236Large | S | Form 4 |
| COLL |
COLLEGIUM PHARMACEUTICAL, INC
|
CFO
10b5-1 Sell
|
2025-11-06 | $200,517 | S | Form 4 |